Dominique Verhelle

Dominique Verhelle

Company: NextRNA Therapeutics

Job title: Co-Founder & CEO


Advancing Novel Target & Drug Discovery Engine to Drug Non-Coding RNAs 3:30 pm

Non-coding RNAs and their interacting proteins represent a vast class of therapeutic targets NextRNA leverages a proprietary target validation platform to identify and prioritize long non-coding RNA therapeutic programs Developing small molecules to specifically disrupt ncRNA-protein interactionsRead more

day: Day One

Breakfast Panel: What does the Future Landscape of Emerging Non-Coding RNA Therapeutics Look Like?

Ranjan Perera
Director RNA Center & Associate Professor, Johns Hopkins University

9:00 am

What are considered as emerging non-coding RNA therapeutics and where is innovation expected to come from? Outlining the advantages and opportunities that emerging long non-coding RNA therapeutics and microRNAs offer Discussing what the next steps are in the research to accelerate these novel therapeutics into the clinicRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.